Douglas C. Wallace
10Patents
4h-index
16Co-inventors
57Inventor score
Filing activity: Dec 8, 1989 → Oct 31, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5185244A | Genetic test for hereditary neuromuscular disease | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5670320A | Detection of mitochondrial DNA mutation 14459 associated with dystonia and/or Leber's hereditary optic neuropathy | Chemistry; Metallurgy | 24 | Expired |
| US5494794A | Detection of mitochondrial DNA mutations associated with Alzheimer's disease and Parkinson's disease | Chemistry; Metallurgy | 14 | Expired |
| US5296349A | Molecular genetic test for myoclonic epilepsy | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6013858A | Mouse lacking heart-muscle adenine nucleotide translocator protein and methods | Human Necessities | 4 | Expired |
| US6900026B2 | Methods for identifying compounds as antioxidants | Human Necessities | 1 | Expired |
| US8203030B2 | Transgenic mouse models for diseases caused by mtDNA mutations and related methods | Human Necessities | 0 | Active |
| US8895312B2 | Nanofluidic platform for single mitochondria analysis | Emerging Cross-Sectional Technologies | 0 | Active |
| US8961759B2 | Device and method for mitochondrial membrane potential assessment | Emerging Cross-Sectional Technologies | 0 | Active |
| US10519502B2 | Mitochondrial disease genetic diagnostics | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.